| Company/Division name | Samsung Biologics |
| Parent company | Samsung Group |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Country(ies) from which reshored: | Korea, Democratic People's Republic of |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biopharmaceutical Contract Development |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Lead time/Time to market, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market |
